Wilf Yeo

Pharmacological Trends in Addiction

Dr. Wilfred Winston YEO, MRCP. MD. FRCP FRACP., University of Wollongong, Australia

Wilf Yeo is the Foundation Professor of Medicine and Clinical Pharmacology at the University of Wollongong (UOW), Graduate Medicine (GM). Before arriving in Australia in January 2007 he was based at the University of Sheffield, UK, and Sheffield Teaching Hospitals NHS Trust. He has over twenty years experience in conducting clinical trials focusing on cardiovascular therapies, or on pharmacokinetic studies of novel drugs. He has published extensively in the fields of preventative cardiovascular medicine and pharmacology. He is a member of the British Hypertension Society, British Pharmacological Society, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Fellow of the Royal College of Physicians London and Royal Australasian College of Physicians and was Clinical Secretary and Vice-President (Clinical) of the BPS between 1999 and 2001. His clinical work includes on-call duties in medicine at the Wollongong Hospital and is the Co-Director for the Illawarra Shoalhaven Local Health District (ISLHD) for Medicine. He is also the Director Teaching Hospitals for the School of Medicine. Wilf was Deputy Director of the Illawarra Health & Medical Research Institute, a joint venture between ISLHD and UOW (2008 – 2014), and was the Director of its Clinical Research and Trials Unit (CRTU, 2008-2015).

You can learn more about him – Wilf Yeo.

He will be speaking on Pharmacological Trends in Addiction

Research has revolutionized our understanding of drug use and addiction, driving a new appreciation of the neurobiological, genetic, epigenetic, social, and environmental factors that contribute to substance use disorders (SUDs). Ground breaking scientific discoveries about the brain and its role in addiction coupled with changes in society’s views are enabling us to respond more effectively to the problem. We are moving away from the misconception that people with addictions are morally flawed and lacking in willpower that resulted in an emphasis on punishment rather than prevention and treatment. The presentation will review the international pharmacological trends in substance use. Research has also identified many evidence-based prevention and treatment strategies, but there remains a frustrating bench-to-bedside gap. There is a persistent failure of effective interventions being distributed and adopted to improve the lives of individuals, families, and communities. The range of treatment options available for most SUDs remains limited. FDA-approved pharmacotherapies exist for dependence on opioids (i.e., methadone, buprenorphine, and extended release naltrexone), alcohol, and nicotine, often used in combination with evidence-based psychosocial treatments. However, the efficacy of these treatments is far from ideal. Data will be presented on progress regarding pharmacological targets for SUDs.


My Sessions

Pharmacological Trends in Addiction